Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII--an open label, exploratory, cross-over, phase I/II study. (Q45859289)
Jump to navigation
Jump to search
scientific article published in November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII--an open label, exploratory, cross-over, phase I/II study. |
scientific article published in November 2010 |
Statements
Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII--an open label, exploratory, cross-over, phase I/II study (English)
J Spira
O Plyushch
R Yatuv
I Dayan
A Bleicher
M Robinson
1 reference